Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
December 12, 2024 17:02 ET
|
Biomea Fusion, Inc.
In preclinical experiments, icovamenib enhanced beta cell function and responsiveness of human islets to GLP-1-based therapies. These effects were associated with an increase in the expression levels...
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India
December 11, 2024 06:00 ET
|
MannKind
CDSCO Approves Afrezza® (insulin human) Inhalation Powder in India
India Diabetes Care Market Report 2024: Focus on Digital Health Solutions and Telemedicine, Personalized Medicine and Data Analytics
December 11, 2024 04:11 ET
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "India Diabetes Care Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases
December 10, 2024 08:00 ET
|
RENAISSTHERA PRIVATE LIMITED
RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases
RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases
December 09, 2024 22:30 ET
|
RENAISSTHERA PRIVATE LIMITED
RenaissThera Closes Seed Funding to Drive AI-Powered Therapies for Cardio-Metabolic Diseases
Type 1 Diabetes Epidemiology Forecast to 2033
December 04, 2024 04:07 ET
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Type 1 Diabetes: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.T1D, formally referred to as...
[Latest] Global Point of Care Glucose Testing Market Size/Share Worth USD 5,455.3 Million by 2033 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 27, 2024 01:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Point of Care Glucose Testing Market Size, Trends and Insights By Product (Accu...
[Latest] Global Injectable Drug Delivery Devices Market Size/Share Worth USD 40,956.3 Million by 2033 at a 10.21% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 25, 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Injectable Drug Delivery Devices Market Size, Trends and Insights By Device Type...
Diabetes Injection Pens Business Analysis Report 2024-2030: Surge in Self-Monitoring Devices, Growth in Reusable Pens, mHealth for Dosage Tracking Fueling Expansion
November 22, 2024 07:45 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Injection Pens - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Diabetes...
Diabetes Care Nutrition Market Report 2024 with Forecasts to 2029 - Meal Replacements Segment is Forecast to Grow at a CAGR of 7.5% During 2024-2029
November 13, 2024 04:25 ET
|
Research and Markets
Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Care Nutrition Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application" report...